Fu Gui
Impact in
- Biological Psychiatry top 10%
- Tryptophan and brain disorders
- Ophthalmology top 5%
- Retinal Diseases and Treatments
Papers in
-
- DNA Repair Mechanisms 2
- Oncology 5
- PARP inhibition in cancer therapy 4
- Co-authors
- Yulan Zhang (2 shared papers)Zhipeng You (2 shared papers)Hongxi Wu (2 shared papers)Shuhua Fu (1 shared paper)Adam S. Kibel (4 shared papers)Zhengdong Hong (3 shared papers)Tomoaki Takai (4 shared papers)Jia Li (5 shared papers)
- Journals
- Science Advances (2 papers)American Journal of Physiology-Gastrointestinal and Liver Physiology (1 paper)EXPERIMENTAL ANIMALS (1 paper)Cell Biology International (1 paper)Brain Research (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Fu Gui
24 papers receiving 585 citations
Peers
Comparison fields: 5 of 83
- Biological Psychiatry 52
- Ophthalmology 88
- Behavioral Neuroscience 23
- Neurology 44
- Nutrition and Dietetics 69
Countries citing papers authored by Fu Gui
This map shows the geographic impact of Fu Gui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fu Gui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fu Gui more than expected).
Fields of papers citing papers by Fu Gui
This network shows the impact of papers produced by Fu Gui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fu Gui. The network helps show where Fu Gui may publish in the future.
Co-authors
The 25 scholars most cited alongside Fu Gui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 129 | |
| 2 | 2020 | 104 | |
| 3 | 2019 | 81 | |
| 4 | 2019 | 35 | |
| 5 | 2016 | 34 | |
| 6 | 2019 | 33 | |
| 7 | 2019 | 28 | |
| 8 | 2022 | 25 | |
| 9 | 2015 | 25 | |
| 10 | 2019 | 17 | |
| 11 | LACTB induced apoptosis of oxaliplatin-resistant gastric cancer through regulating autophagy-mediated mitochondrial apoptosis pathway. | 2021 | 17 |
| 12 | 2022 | 15 | |
| 13 | 2021 | 10 | |
| 14 | 2021 | 9 | |
| 15 | 2016 | 7 | |
| 16 | 2019 | 7 | |
| 17 | 2022 | 4 | |
| 18 | 2021 | 4 | |
| 19 | 2025 | 2 | |
| 20 | 2012 | 2 |
About Fu Gui
Fu Gui is a scholar working on Molecular Biology, Oncology, Epidemiology, Pulmonary and Respiratory Medicine and Ophthalmology, having authored 25 papers that have together received 592 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (4 papers), Pancreatitis Pathology and Treatment (2 papers), Microbial Natural Products and Biosynthesis (2 papers), Ophthalmology and Visual Impairment Studies (2 papers), Renal cell carcinoma treatment (2 papers), Prostate Cancer Treatment and Research (2 papers), DNA Repair Mechanisms (2 papers) and Fungal Biology and Applications (2 papers). The work is most often cited by research in Biological Psychiatry (52 citations), Ophthalmology (88 citations), Behavioral Neuroscience (23 citations), Neurology (44 citations) and Nutrition and Dietetics (69 citations). Fu Gui has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Yulan Zhang, Zhipeng You, Hongxi Wu, Shuhua Fu, Adam S. Kibel, Zhengdong Hong, Tomoaki Takai, Jia Li, Runming Jin and Xiao Bai. Their work appears in journals such as Science Advances, American Journal of Physiology-Gastrointestinal and Liver Physiology, EXPERIMENTAL ANIMALS, Cell Biology International and Brain Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.